ESFENVALERATE FREE ACID METABOLITE

CAS55332-38-2

ESFENVALERATE FREE ACID METABOLITE (CAS 55332-38-2, C11H13ClO2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of ESFENVALERATE FREE ACID METABOLITE
C11H13ClO2 · 212.68 g/mol
CAS No.
55332-38-2
Formula
C11H13ClO2
Mol. weight
212.68 g/mol

Chemical Specifications

Identifiers

CAS number 55332-38-2
Product name ESFENVALERATE FREE ACID METABOLITE
Chinese name S-2-(4-氯苯基)-3-甲基丁酸
Synonyms S-2-(4-chlorophenyl)-3-methylbutyricacid
Chinese synonyms S-2-(4-氯苯基)-3-甲基丁酸; 顺式氰戊菊酯自由酸代谢物, 10ΜG /ΜL于环己烷
Molecular formula C11H13ClO2
Molecular weight 212.68 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of ESFENVALERATE FREE ACID METABOLITE?

The CAS Registry Number of ESFENVALERATE FREE ACID METABOLITE is 55332-38-2. ESFENVALERATE FREE ACID METABOLITE is also known as S-2-(4-chlorophenyl)-3-methylbutyricacid.

What is the molecular formula and molecular weight of ESFENVALERATE FREE ACID METABOLITE?

The molecular formula of ESFENVALERATE FREE ACID METABOLITE is C11H13ClO2, and its molecular weight is 212.68 g/mol.

How can I request a quotation for ESFENVALERATE FREE ACID METABOLITE?

Send an inquiry for ESFENVALERATE FREE ACID METABOLITE (CAS 55332-38-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for ESFENVALERATE FREE ACID METABOLITE

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.